HUTCHMED (China) (HCM) Earnings Date & Reports

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

HCM is expected to report earnings to -69 cents per share on November 11

HUTCHMED (China) HCM Stock Earnings Reports

Q3'22

Est.

$-0.70

Q4'23

Beat

by $0.38

Q2'23

Beat

by $1.03

Q4'22

Est.

$-1.02

Q2'22

Missed

by $0.24

The last earnings report on February 28 showed earnings per share of -69 cents, beating the estimate of -108 cents. With 68.60K shares outstanding, the current market capitalization sits at 2.88B.

View a ticker or compare two or three

Compare

HCM